1028486-10-3

Basic information

• Product Name: 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid ammonium salt
• Synonyms: 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid ammonium salt
• CAS NO: 1028486-10-3
• Molecular Weight: 535.962
• Mol File: 1028486-10-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid ammonium salt(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid ammonium salt(1028486-10-3)
• EPA Substance Registry System: 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid ammonium salt(1028486-10-3)

Safety Data

• Hazardous Substances Data: 1028486-10-3(Hazardous Substances Data)

Upstream product

• 1028486-08-9 4-{[amino(imino)methyl]amino}-2-methoxybenzoic acid hydrochloride 

Downstream Products

• 1028486-01-2 alisertib 

Relevant articles and documents

COMPOUNDS FOR INHIBITING MITOTIC PROGRESSION

The present invention relates to compounds of formula (I) : and methods for the treatment of cancer. In particular, the invention provides potent inhibitors of Aurora A kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.